Trial · NCT07900919
OB VEGA-Phenylephrine vs Norepinephrine Outcomes
NCT07900919, Phase 4, Not yet recruiting, Wake Forest University Health Sciences
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. OB VEGA-Phenylephrine vs Norepinephrine Outcomes. Trials, record NCT07900919. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07900919
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- OB VEGA-Phenylephrine vs Norepinephrine Outcomes
- NCT number
- NCT07900919
- Status
- Not yet recruiting
- Phases
- Phase 4
- Enrollment
- 1,500 participants, estimated
- Lead sponsor
- Wake Forest University Health Sciences
- Conditions
- Hypotension During Surgery, Cesarean Birth
- Interventions
- Phenylephrine, Norepinephrine
- First posted
- 2026-10-28
- Last updated
- 2026-10-28
Source ClinicalTrials.gov
Registered outcomes13
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change in Uterine tone-obstetrician evaluation scores | up to 2 hours | measured by 0-10 numeric rating scale (0 = atonic, 10 = firm/optimal), assessed by obstetrician blinded to group, at fixed timepoints (2, 5, 10 minutes after delivery) - higher scores denoting more desirable |
| Primary | Change in Uterine tone-obstetrician evaluation scores with Uterine tone-uterotonic drug administration | up to 2 hours | measured by 0-10 numeric rating scale (0 = atonic, 10 = firm/optimal), assessed by obstetrician blinded to group, at fixed timepoints (2, 5, 10 minutes after delivery) - higher scores denoting more desirable - measured by addition of supplemental uterotonics - methylergonivine, carboprost, misoprostol, total amount of oxytocin over 20 minutes post delivery |
| Primary | Uterine tone-blood loss amount | hour 24 | Quantitative blood loss (QBL) via gravimetric sponge/lap weighing plus calibrated suction canister volume, corrected for irrigation fluid |
| Primary | Uterine tone-blood loss amount - Postoperative hemoglobin drop | hour 24 | Quantitative blood loss (QBL) Postoperative hemoglobin drop (pre-op minus postoperative day 1 hemoglobin) |
| Secondary | Incidence of Hypotension | up to 2 hours | systolic blood pressure \<80% baseline |
| Secondary | Incidence of Bradycardia | up to 2 hours | heart rate \<60bpm |
| Secondary | Number of rescue boluses of vasopressor | up to 2 hours | number of rescue bolus doses of vasopressors used |
| Secondary | Nausea | up to 2 hours | presence or absence of nausea occurring |
| Secondary | Intraoperative nausea/vomiting (yes/no) | up to 2 hours | presence or absence of vomiting occurring |
| Secondary | umbilical blood gas | up to 2 hours | if done, measurement of pH, base excess, and lactate |
1 to 10 of 13Source ClinicalTrials.gov
See all 13 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07900919
GET https://conductscience.org/api/trials/v1/NCT07900919/registered